Trials / Unknown
UnknownNCT02020954
Prospective Becker-Heart-Study
Prospective Cohort Study of Patients With Mutations in the Dystrophin Gene (X Linked Dilated Cardiomyopathy and Becker Muscular Dystrophy)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Karim WAHBI · Academic / Other
- Sex
- Male
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether electrocardiogram, echocardiography, cardiac MRI, sera biomarkers can improve early detection of myocardial involvement and clinical outcome.
Detailed description
A cohort of 100 patients with mutations in the dystrophin gene associated with Becker muscular dystrophy and/or dilated cardiomyopathy will be included (patients with Duchenne muscular dystrophy are excluded). Patients with undergo at baseline the following workups: electrocardiogram, echocardiography, cardiac MRI, sera biomarkers measurement. At 3 years and 5 years, patients will be investigated according to the same protocol and occurrence of cardiac adverse events in the meanwhile will be recorded. Statistical analysis will assess correlations between cardiac phenotype and DMD mutations and prognostic value of cardiac investigations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ECG, echocardiography, cardiac MRI, sera biomarkers |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2013-12-25
- Last updated
- 2015-03-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02020954. Inclusion in this directory is not an endorsement.